Anika Therapeutics, Inc. (ANIK) Form 8-K — Jun 23, 2026
$ANIKForm 8-KItems 5.02, 5.07, 9.01Filed Jun 23, 2026, 8:00 AM ET0001171843-26-004253Original filing
Anika Therapeutics, Inc. announced that shareholders approved amendments to its 2017 Omnibus Incentive Plan and 2021 Employee Stock Purchase Plan during the June 18, 2026 annual meeting. The amendments increase the number of shares reserved under the Omnibus Plan by 350,000 shares to a total of 6,110,000 shares, and under the ESPP by 200,000 shares to a total of 400,000 shares. Shareholders also re-elected Gary P.
Key figures
- Espp shares increase
- 200000
- Espp shares reserved
- 400000
- Omnibus plan shares increase
- 350000
- Omnibus plan shares reserved
- 6110000
Price after filing
1 day: +1.0%7 days: +0.3%30 days: +2.9%
Close on the filing date to close N calendar days later (from $14.59). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.